Laval, Canada

Anna N Moraitis

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2015-2021

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Anna N Moraitis

Introduction

Anna N Moraitis is a prominent inventor based in Laval, Canada, known for her significant contributions to cancer research and treatment. With a total of six patents to her name, she has focused on developing innovative methods for targeting and treating various types of cancer, particularly breast cancer.

Latest Patents

Among her latest patents is a groundbreaking method for treating breast cancer, specifically targeting triple-negative breast cancer cells. This method utilizes an anti-KAAG1 antibody to effectively kill cancer cells that lack ER protein expression, PgR protein expression, and/or show an absence of HER2 protein over-expression. The patent also discusses the use of antibody conjugates in the treatment of triple-negative and basal-like breast cancer. Additionally, she has developed novel antibodies and antigen binding fragments that specifically bind to KAAG1, which can be used for the detection and therapeutic treatment of various cancers, including ovarian, renal, lung, colorectal, breast, brain, and prostate cancers.

Career Highlights

Throughout her career, Anna has worked with notable companies such as Alethia Biotherapeutics Inc. and ADC Therapeutics SA. Her work in these organizations has contributed to the advancement of cancer therapies and has positioned her as a key figure in the field of biotherapeutics.

Collaborations

Anna has collaborated with esteemed colleagues, including Gilles Bernard Tremblay and Mario Filion, to further her research and development efforts in cancer treatment.

Conclusion

Anna N Moraitis continues to make significant strides in the field of cancer research, with her innovative patents paving the way for new therapeutic options. Her dedication to improving cancer treatment is evident in her work and collaborations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…